` NDRA (ENDRA Life Sciences Inc) vs S&P 500 Comparison - Alpha Spread

NDRA
vs
S&P 500

Over the past 12 months, NDRA has underperformed S&P 500, delivering a return of -24% compared to the S&P 500's +18% growth.

Stocks Performance
NDRA vs S&P 500

Loading
NDRA
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NDRA vs S&P 500

Loading
NDRA
S&P 500
Difference
www.alphaspread.com

Performance By Year
NDRA vs S&P 500

Loading
NDRA
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
ENDRA Life Sciences Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

ENDRA Life Sciences Inc
Glance View

Market Cap
5.3m USD
Industry
Health Care

ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 22 full-time employees. The company went IPO on 2017-06-28. The firm has developed a technology platform, Thermo Acoustic Enhanced Ultrasound (TAEUS), which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis and treatment of various other medical conditions. Its TAEUS technology platform application focuses on quantifying fat in the liver and stage progression of non-alcoholic fatty liver disease (NAFLD), which untreated, can progress to Non-alcoholic Steatohepatitis (NASH), fibrosis, cirrhosis, and liver cancer. The firm's TAEUS platform has various clinical applications, such as tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.

NDRA Intrinsic Value
Not Available
Back to Top